I. Farmer

EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy

M. Dowsett, S. Pancholi, D. Evans, 2010, British Journal of Cancer.

Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.

M. Dowsett, Simak Ali, S. Johnston, 2005, Endocrine-related cancer.

Enhanced Estrogen Receptor (ER) α, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen Deprivation*

M. Dowsett, Simak Ali, S. Johnston, 2003, Journal of Biological Chemistry.

The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling.

I Farmer, M. Dowsett, S. Pancholi, 2005, Endocrine-related cancer.

Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo

M. Dowsett, H. Lane, S. Johnston, 2012, Breast Cancer Research.

The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling

M. Dowsett, S. Pancholi, L.-A. Martin, 2005, Breast Cancer Research.

Enhanced ERα, ERBB2 and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term oestrogen deprivation

M. Dowsett, Simak Ali, S. Johnston, 2003 .